1.
Ostrovskaya O, Sips M, Ulrichts P, Trainor L, Verheesen P, Stoykov I. Efgartigimod: Clinical Development of a Novel FcRn Antagonist in the Treatment of Autoimmune Diseases. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s193. Available from: https://jofskin.org/33014/index.php/skin/article/view/1950